Trial Profile
A Phase III, Randomized, Active-Controlled, Parallel-Group Clinical Trial to Study the Efficacy and Long-Term Safety of Mometasone Furoate/Formoterol Fumarate (MF/F, MK-0887A [SCH418131]), Compared With Mometasone Furoate (MF, MK-0887 [SCH032088]), in Children With Persistent Asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Mometasone/formoterol (Primary) ; Mometasone; Prednisolone; Prednisone; Salbutamol
- Indications Asthma
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon
- 02 Jan 2018 Status changed from active, no longer recruiting to completed.
- 22 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 23 May 2016 Status changed from not yet recruiting to recruiting.